Publicaciones en las que colabora con Óscar Lorenzo González (20)

2024

  1. Cardiac Rehabilitation Increases Plasma Klotho Levels

    Journal of Clinical Medicine, Vol. 13, Núm. 6

  2. Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome

    ESC Heart Failure, Vol. 11, Núm. 1, pp. 240-250

2023

  1. Absence of High Lipoprotein(a) Levels Is an Independent Predictor of Acute Myocardial Infarction without Coronary Lesions

    Journal of Clinical Medicine, Vol. 12, Núm. 3

2022

  1. Impact of renal function on the prognostic value of mineral metabolism in patients with chronic ischaemic heart disease patients with chronic ischaemic heart disease

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 1, pp. 1-9

  2. NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease

    Journal of Clinical Medicine, Vol. 11, Núm. 14

2021

  1. Mcp-1 predicts recurrent cardiovascular events in patients with persistent inflammation

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-13

  2. N-terminal pro-brain natriuretic peptide plasma levels are associated with intermediate-term follow-up cancer in coronary patients

    Journal of Clinical Medicine, Vol. 10, Núm. 18

  3. Parathormone levels add prognostic ability to N-terminal pro-brain natriuretic peptide in stable coronary patients

    ESC Heart Failure, Vol. 8, Núm. 4, pp. 2713-2722

2020

  1. Galectin-3 is associated with cardiovascular events in post-acute coronary syndrome patients with type-2 diabetes

    Journal of Clinical Medicine, Vol. 9, Núm. 4

2017

  1. Comparison of 3 predictive clinical risk scores in 603 patients with stable coronary artery disease

    Texas Heart Institute Journal, Vol. 44, Núm. 4, pp. 239-244

  2. Sun exposure influences the prognostic power of components of mineral metabolism in patients with coronary artery disease

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 27, Núm. 9, pp. 762-767

  3. Use of proton-pump inhibitors predicts heart failure and death in patients with coronary artery disease

    PLoS ONE, Vol. 12, Núm. 1

2016

  1. Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease

    Diabetes/Metabolism Research and Reviews, Vol. 32, Núm. 7, pp. 685-693

  2. Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate

    Journal of Bone and Mineral Metabolism, Vol. 34, Núm. 5, pp. 587-598

2015

  1. Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors

    Journal of Cardiology, Vol. 66, Núm. 1, pp. 22-27

  2. Impacto de los niveles plasmáticos de pro-péptido natriurético tipo B aminoterminal, proteína quimiotáctica de monocitos-1 y galectina3 en la capacidad predictiva de eventos de la escala clínica LIPID en la enfermedad coronaria estable

    Clinica e Investigacion en Arteriosclerosis, Vol. 27, Núm. 2, pp. 57-63

  3. N-terminal pro-brain natriuretic peptide is associated with a future diagnosis of cancer in patients with coronary artery disease

    PLoS ONE, Vol. 10, Núm. 6

  4. The Prognostic Value of High-Sensitive Troponin i in Stable Coronary Artery Disease Depends on Age and Other Clinical Variables

    Cardiology (Switzerland), Vol. 132, Núm. 1, pp. 1-8

2014

  1. Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease

    PLoS ONE, Vol. 9, Núm. 4

  2. Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease

    American Journal of Cardiology, Vol. 113, Núm. 3, pp. 434-440